阳光诺和: 关于披露重大资产重组预案的一般风险提示暨公司股票复牌的公告

Group 1 - The company plans to acquire 100% equity of Jiangsu Langyan Life Science Technology Holdings Co., Ltd. through the issuance of shares and convertible bonds, while also raising matching funds from no more than 35 specific investors [3] - The company's stock was suspended from trading starting April 25, 2025, due to the planned asset acquisition and fundraising activities [3][4] - The stock is scheduled to resume trading on May 13, 2025, after the completion of relevant audits and evaluations [4] Group 2 - The board of directors has decided not to hold a shareholders' meeting to review the transaction until the audit and evaluation work is completed [4] - The company will continue to fulfill its information disclosure obligations in accordance with relevant laws and regulations after the stock resumes trading [4][5] - All information regarding the transaction will be disclosed through the Shanghai Stock Exchange website and designated media [5]